VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces that President and Group Chief Executive Officer, Cameron Reynolds, has issued a Shareholder Letter providing a ...

Meanwhile, Cadence and Intel Foundry are engaging in early design technology co-optimization for Intel 14A-E to establish the readiness of Cadence EDA flows for the next-generation advanced node.